Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer

Journal of Human Genetics

Volumn 59, Issue 7, 2014, Pages 381-386

  Freriksen, Jolien J M ^a   Salomon, Jody ^a   Roelofs, Hennie M J ^a   Te Morsche, Rene H M ^a   Van Der Stappen, Jos W J ^b   Dura, Polat ^a   Witteman, Ben J M ^c   Lacko, Martin ^d   Peters, Wilbert H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c GELDERSE VALLEI HOSPITAL   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROQUINONE DERIVATIVE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) 1; UNCLASSIFIED DRUG; NQO1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; ASCENDING COLON; ASCENDING COLON CANCER; CANCER RISK; CATALYSIS; CLINICAL EVALUATION; COLON CANCER; COLON CARCINOGENESIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; CASE CONTROL STUDY; COLONIC NEOPLASMS; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; RISK;

ALLELES; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NAD(P)H DEHYDROGENASE (QUINONE); NETHERLANDS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84905026006     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2014.38     Document Type: Article

References (36)

1. STATLINE. Sterfte; kerncijfers naar diverse kenmerken Centraal Bureau voor de Statistiek (2012
2. IAfRoC. World Cancer Report 2008 (World Health Organization, Lyon, France, 2008
3. Randi, G., Edefonti, V., Ferraroni, M., La Vecchia, C. & Decarli, A. Dietary patterns and the risk of colorectal cancer and adenomas. Nutr. Rev. 68, 389-408 (2010
4. Menon, R., Riera, A. & Ahmad, A. A global perspective on gastrointestinal diseases. Gastroenterol. Clin. N. Am. 40, 427-439 (2011
5. Racette, A L. & Miller, R. T. Esophageal carcinoma: Matching patients with treatment methods. JAAPA 24, 28-31 (2011
6. Chen, B., Zhou, Y., Yang, P. & Wu, X. T. Glutathione S-Transferase M1 gene polymorphism and gastric cancer risk: An updated analysis. Arch. Med. Res. 41, 558-566 (2010
7. Zhu, C. L., Huang, Q., Liu, C. H., Lin, X. S., Xie, F. & Shao, F. NAD(P)H: Quinone Oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: A meta-Analysis. Asian Pac. J. Cancer Prev. 14, 2349-2354 (2013
8. Ross, D., Kepa, J. K., Winski, S. L., Beall, H. D., Anwar, A. & Siegel, D. NAD(P)H: Quinone oxidoreductase 1 (NQO1): Chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem. Biol. Interact. 129, 77-97 (2000
9. Traver, R. D., Siegel, D., Beall, H. D., Phillips, R. M., Gibson, N. W., Franklin, W. A. et al. Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DTdiaphorase). Br. J. Cancer 75, 69-75 (1997
10. Asher, G., Lotem, J., Kama, R., Sachs, L. & Shaul, Y. NQO1 stabilizes p53 through a distinct pathway. Proc. Natl Acad. Sci. USA 99, 3099-3104 (2002
11. Yu, H., Liu, H., Wang, L E. & Wei, Q. A functional NQO1 609C4T polymorphism and risk of gastrointestinal cancers: A meta-Analysis. PLoS ONE 7, e30566 (2012
12. Kuehl, B. L., Paterson, J. W., Peacock, J. W., Paterson, M. C. & Rauth, A. M. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br. J. Cancer 72, 555-561 (1995
13. Yang, F. Y., Guan, Q. K., Cui, Y. H., Zhao, Z. Q., Rao, W. & Xi, Z. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: A meta-Analysis based on 21 case-control studies. Eur. J. Cancer Prev. 21, 432-441 (2012
14. Mandal, R. K., Nissar, K. & Mittal, R. D. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: A study from North India. Mol. Biol. Rep. 39, 11145-11152 (2012
15. Sies, H & Packer, L. Quinones and quinone enzymes. Methods Enzymol. 382 (2004
16. Pan, S S., Forrest, G. L., Akman, S. A. & Hu, L. T. NAD(P)H: Quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. Cancer Res. 55, 330-335 (1995
17. Malik, M. A., Zargar, S. A. & Mittal, B. Role of NQO1 609C4T and NQO2-3423G4A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis. Mol. Biol. Rep. 39, 9095-9104 (2012
18. Wang, Z., Hu, J. & Zhong, J. Meta-Analysis of the NAD(P)H: Quinine oxidoreductase 1 gene 609 C4T polymorphism with esophageal cancer risk. DNA Cell. Biol. 31, 560-567 (2012
19. Zhang, J., Schulz, W A., Li, Y., Wang, R., Zotz, R., Wen, D. et al. Association of NAD(P)H: Quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis 24, 905-909 (2003
20. Zhang, J. H., Li, Y., Wang, R., Zhang, J. H., Li, Y., Wang, R. et al. NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J. Gastroenterol. 9, 1390-1393 (2003
21. Sarbia, M., Bitzer, M., Siegel, D., Ross, D., Schulz, W. A. & Zotz, R. B. Association between NAD(P)H: Quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int. J. Cancer 107, 381-386 (2003
22. Yanling, H., Yuhong, Z., Wenwu, H., Lei, X. & Mingwu, C. NQO1 C609T polymorphism and esophageal cancer risk: A HuGE review and meta-Analysis. BMC Med. Genet. 14, 31 (2013
23. Begleiter, A., Hewitt, D., Maksymiuk, A. W., Ross, D. A. & Bird, R. P. A NAD(P)H: Quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer. Cancer Epidemiol. Biomarkers Prev. 15, 2422-2426 (2006
24. Chen, J., Lin, Y., Zhang, R., Huang, Z. J. & Pan, X. G. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: A meta-Analysis. Arch. Med. Res. 43, 58-66 (2012
25. Ding, R., Lin, S. & Chen, D. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: A meta-Analysis. Int. J. Colorectal. Dis. 27, 885-892 (2012
26. Peng, X E., Jiang, Y. Y., Shi, X. S. & Hu, Z. J. NQO1 609C4T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population. Gene 521, 105-110 (2013
27. Van Der Logt, E. M., Bergevoet, S. M., Roelofs, H. M. J., te Morsche, R. H. M., Van Dijk, Y., Wobbes, T. et al. Role of epoxide hydrolase, NAD(P)H: Quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. Mutat. Res. 593, 39-49 (2006
28. Begleiter, A., Norman, A., Leitao, D., Cabral, T., Hewitt, D., Pan, S et al. Role of NQO1 polymorphisms as risk factors for squamous cell carcinoma of the head and neck. Oral Oncol. 41, 927-933 (2005
29. Li, G., Liu, Z., Sturgis, E. M., Chamberlain, R. M., Spitz, M. R. & Wei, Q. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol. Biomarkers Prev. 14, 1034-1036 (2005
30. Gaedigk, A., Tyndale, R. F., Jurima-Romet, M., Sellers, E. M., Grant, D. M. & Leeder, J. S. NAD(P)H: Quinone oxidoreductase: Polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations. Pharmacogenetics 8, 305-313 (1998
31. Bufill, J. A. Colorectal cancer: Evidence for distinct genetic categories based on proximal or distal tumor location. Ann. Intern. Med. 113, 779-788 (1990
32. Iacopetta, B. Are there two cites to colorectal cancer. Int. J. Cancer 101, 403-408 (2002
33. Cho, C. G., Lee, S. K., Nam, S. Y., Lee, M. S., Lee, S. W., Choi, E. K. et al. Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk. J. Korean Med. Sci. 21, 1075-1079 (2006
34. Yuan, W., Xu, L., Chen, W., Wang, L., Fu, Z., Pang, D. et al. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: A meta-Analysis. Breast Cancer Res. Treat. 125, 467-472 (2011
35. Saldivar, S. J., Wang, Y., Zhao, H., Shao, L., Lin, J., Spitz, M. R. et al. An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat. Res. 582, 71-78 (2005
36. Hu, X., Zhang, Z., Ma, D., Huettner, P. C., Massad, L. S., Nguyen, L. et al. TP53, MDM2, NQO1, and susceptibility to cervical cancer. Cancer Epidemiol. Biomarkers Prev. 19, 755-761 (2010.